July 3, 2019
Authored and Edited by Samhitha Muralidhar Medatia; Elizabeth D. Ferrill; Brad D. Richards*
The decision in Hyosung TNS Inc. v. ITC demonstrated the importance of an investment in research and development when bringing an investigation before the ITC. The ITC requires a complainant to have a domestic industry (“DI”) over its IP-protected good or service. The controlling statute allows R&D investments related to the protected product to count for DI, but it is silent on the time period to consider. Hyosung originally argued that a multi-million-dollar investment, spent over five years before the investigation, was too far back in time to consider for the purposes of DI. The ITC, however, found that the investment was sufficiently tied to current practices that were influenced by the R&D results. On appeal, Hyosung argued for a new legal standard: investments from more than five years ago cannot count toward DI. The CAFC found “nothing in the statutory language that supports” that position and rejected Hyosung’s proposal. The CAFC dismissed Hyosung’s other arguments (1) that the asserted patent was obvious, and (2) that the other asserted (and expired) patent did not make the ITC orders over the protected products moot.
*Brad D. Richards is a Summer Associate at Finnegan
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.